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Abbreviations {#feb213352-sec-0001}
=============

**Amp**, ampicillin

**BSD2**, bundle sheath defective protein 2

**Cam**, chloramphenicol

**Cpn**, chloroplast chaperonin

**ECM**, enzyme‐CO~2~‐magnesium

**EI**, enzyme inhibited

**GAPDH**, glyceraldehyde‐3‐phosphate dehydrogenase

**GPDH**, glycerol 3‐phosphate dehydrogenase

**Kan**, kanamycin

**NADH**, nicotinamide adenine dinucleotide (reduced form)

**PGK**, phosphoglycerate kinase

**Raf**, Rubisco accumulation factor

**RbcL**, Rubisco large subunit

**RbcS**, Rubisco small subunit

**Rca**, Rubisco activase

**RuBP**, ribulose‐1, 5‐biphosphate

**SEC**, size‐exclusion chromatography

**Spec**, spectinomycin

**TIM**, triose phosphate isomerase

 {#feb213352-sec-0002}

Ribulose‐1,5‐bisphosphate carboxylase/oxygenase (Rubisco), the key enzyme of the Calvin‐Benson‐Bassham cycle of photosynthesis, is responsible for the entry of atmospheric carbon dioxide (CO~2~) into the biosphere by catalyzing the carboxylation of its five carbon sugar substrate ribulose‐1,5‐bisphosphate (RuBP). Plant Rubisco has a low catalytic rate (\~ 2--5 CO~2~·s^−1^ per active site) and thus chloroplasts produce vast amounts of Rubisco, making up to 50% of the total leaf protein and reaching concentrations exceeding 200 mg·mL^−1^ [1](#feb213352-bib-0001){ref-type="ref"}, [2](#feb213352-bib-0002){ref-type="ref"}, [3](#feb213352-bib-0003){ref-type="ref"}. Moreover, the specificity of Rubisco for CO~2~ versus O~2~ is limited, resulting in energetically wasteful oxygenation of RuBP, a process known as photorespiration [4](#feb213352-bib-0004){ref-type="ref"}. Rubisco is a hexadecameric complex of \~ 530 kDa consisting of eight large (RbcL, \~ 53 kDa) and eight small (RbcS, 13 kDa) subunits. The RbcL subunit requires the chloroplast chaperonin (Cpn60) and its cofactors (Cpn20/Cpn10) for folding [2](#feb213352-bib-0002){ref-type="ref"}, but remains unstable and aggregation‐prone prior to assembly with RbcS [5](#feb213352-bib-0005){ref-type="ref"} (Fig. [1](#feb213352-fig-0001){ref-type="fig"}). As shown recently, assembly of the Rubisco holoenzyme (RbcL~8~S~8~) from *Arabidopsis thaliana* upon recombinant expression in *Escherichia coli* requires four auxiliary factors [5](#feb213352-bib-0005){ref-type="ref"} (Fig. [1](#feb213352-fig-0001){ref-type="fig"}): Rubisco accumulation factor 1 (Raf1) [6](#feb213352-bib-0006){ref-type="ref"}, [7](#feb213352-bib-0007){ref-type="ref"}; Rubisco accumulation factor 2 (Raf2) [8](#feb213352-bib-0008){ref-type="ref"}, [9](#feb213352-bib-0009){ref-type="ref"}, [10](#feb213352-bib-0010){ref-type="ref"}; Bundle sheath defective‐2 (BSD2) [5](#feb213352-bib-0005){ref-type="ref"}, [11](#feb213352-bib-0011){ref-type="ref"}; and RbcX [12](#feb213352-bib-0012){ref-type="ref"}, [13](#feb213352-bib-0013){ref-type="ref"}, [14](#feb213352-bib-0014){ref-type="ref"}, [15](#feb213352-bib-0015){ref-type="ref"}.

![Model of chaperone‐assisted folding and assembly of plant Rubisco. Upon folding of newly synthesized RbcL subunits by the Cpn60αβ/Cpn20 chaperonin system, RbcL assembly to RbcL dimers and higher oligomers is mediated by Raf1 and RbcX acting in cooperation or in parallel. Binding of BSD2 causes the displacement of these factors and stabilizes RbcL~8~ cores in a state competent for association with RbcS. RbcS binding causes displacement of BSD2, forming the functional holoenzyme. Raf2 is essential for Rubisco biogenesis [5](#feb213352-bib-0005){ref-type="ref"}; however, its function is as yet unknown. Raf2 may act either downstream or upstream of the chaperonin system. Figure reproduced from Ref. [5](#feb213352-bib-0005){ref-type="ref"}.](FEB2-593-611-g001){#feb213352-fig-0001}

Modifications to plant Rubisco or heterologous expression of alternative isoforms is central to improving photosynthesis [16](#feb213352-bib-0016){ref-type="ref"}, [17](#feb213352-bib-0017){ref-type="ref"}. Reduction of Rubisco oxygenation activity can offer a large improvement to photosynthetic output [18](#feb213352-bib-0018){ref-type="ref"} and improved carboxylation rates are predicted to provide similar enhancements [19](#feb213352-bib-0019){ref-type="ref"}. Mutagenesis and engineering of Rubisco in plants is time‐consuming and labor‐intensive, with deleterious mutations resulting in crippled plants which can only grow in tissue culture [20](#feb213352-bib-0020){ref-type="ref"}, [21](#feb213352-bib-0021){ref-type="ref"}, [22](#feb213352-bib-0022){ref-type="ref"}. Green algae, capable of heterotrophic growth, provide an alternative host for the analysis of plant Rubisco mutants. However, the incompatibility of assembly chaperones and low transformation efficiency limit the usefulness of this approach for high throughput screening in directed evolution [16](#feb213352-bib-0016){ref-type="ref"}. Recombinant expression in a bacterial host would therefore greatly facilitate efforts at engineering plant Rubisco.

Functional bacterial expression of *A. thaliana* Rubisco was recently achieved using a sequential expression strategy where the chloroplast chaperonin and the four specific assembly chaperones were pre‐expressed, followed by Rubisco induction [5](#feb213352-bib-0005){ref-type="ref"}. This approach was designed to avoid overburdening the biosynthetic machinery. However, the yield of functional Rubisco was moderate. In this study, we present a simplified, highly efficient strategy to express and purify functional *A. thaliana* Rubisco from *E. coli*. The novel aspects of this strategy are the following: (a) Expression of Rubisco and all chaperones is simultaneously induced from isopropyl β‐[d]{.smallcaps}‐1‐thiogalactopyranoside (IPTG) regulated plasmids. (b) RbcS is expressed with a C‐terminal hexahistidine‐tag which further improves assembly efficiency and facilitates purification of the holoenzyme.

Materials and methods {#feb213352-sec-0003}
=====================

Plasmid construction {#feb213352-sec-0004}
--------------------

### pET28‐*At*RbcLS {#feb213352-sec-0005}

The *rbcLS* operon was amplified from the vector pBAD33‐*At*RbcLS [5](#feb213352-bib-0005){ref-type="ref"} using the primers 5GibAtL and 3GibAtS. The backbone of the pET28b vector was amplified from the commercially available expression vector pET28b using the primers pET28bopenFor and pET28bopenRev (Table [S1](#feb213352-sup-0001){ref-type="supplementary-material"}). The *rbcLS* and pET28b fragments were ligated using NEB Gibson Assembly^®^ master mix (NEB), as per manufacturer\'s instructions, to generate the plasmid pET28‐*At*RbcLS.

### *At*RbcLS^His6^ {#feb213352-sec-0006}

To introduce a C‐terminal hexahistidine‐tag (His6‐tag) to *rbcS3* and create the plasmid pET28‐*At*RbcLS^His6^, the stop codon (TAA) at the end of the *rbcS3* coding sequence was replaced by an alanine codon (GCA) by site‐directed mutagenesis (QuikChange site‐directed mutagenesis kit; Agilent Technologies, Santa Clara, CA, USA) using the *rbcS3‐his‐fwd* and *rbcS3‐his‐rev* primers (Table [S1](#feb213352-sup-0001){ref-type="supplementary-material"}), effectively fusing the coding sequence of *rbcS3* to the His6‐tag of the pET28b vector, resulting in the insertion of the amino‐acid sequence ALEHHHHHH at the C terminus of the RbcS protein.

### pET28‐Ub‐*At*Rcaβ {#feb213352-sec-0007}

The *A. thaliana* Rubisco activase (β isoform) (*At*Rcaβ) was cloned into the pHUE plasmid, which contains a N‐terminal, cleavable fusion with His6‐ubiquitin [23](#feb213352-bib-0023){ref-type="ref"}. The His6‐ubiquitin *At*Rcaβ was cloned into a pET28b vector between NcoI and XhoI restriction sites to generate the pET28‐Ub‐*At*Rcaβ plasmid.

Protein expression {#feb213352-sec-0008}
------------------

*Escherichia coli* were grown using Luria‐Bertani (LB) broth or LB agar containing the following antibiotic concentrations when required: 100 μg·mL^−1^ ampicillin (Amp), 32 μg·mL^−1^ chloramphenicol (Cam), 100 μg·mL^−1^ spectinomycin (Spec), and/or 30 μg·mL^−1^ kanamycin (Kan). The *E. coli* strain BL21 Star™ (DE3) (Thermo Fisher Scientific Inc., Waltham, MA, USA), designed to improve mRNA stability [24](#feb213352-bib-0024){ref-type="ref"}, was used for new bacterial cell line constructions. This strategy was used to improve Rubisco yield consistency between experiments. As shown previously, each open reading frame (ORF) requires its own ribosome‐binding site for successful plant Rubisco assembly in *E. coli* [5](#feb213352-bib-0005){ref-type="ref"} (Fig. [2](#feb213352-fig-0002){ref-type="fig"}). Plasmid pET11a‐*At*C60αβ/C20 was transformed into electrocompetent BL21 Star™ (DE3) cells which were recovered and plated to LB agar containing Amp prior to growth at 37 °C. These cells were then prepared as electrocompetent and transformed with plasmid pDUET‐*At*R1/R2/RX/B2 and recovered on LB agar containing Amp and Spec. Again electrocompetent cells were prepared and transformed with either plasmid pET28b or pET28‐*At*RbcLS or pET28‐*At*RbcLS^His6^ and recovered on LB agar containing Amp, Spec, and Kan. The strain expressing *A. thaliana* Rubisco under arabinose induction was generated by transforming the electrocompetent cells containing plasmids pET11a‐*At*C60αβ/C20 and pDUET‐*At*R1/R2/RX/B2 with plasmid pBAD33‐*At*RbcLS [5](#feb213352-bib-0005){ref-type="ref"}, and was propagated on LB agar containing Amp, Spec, and Cam.

![(A) Operon organization of plasmids used in the sequential expression of auxiliary factors and Rubisco from *Arabidopsis thaliana* by induction with IPTG and arabinose [5](#feb213352-bib-0005){ref-type="ref"}. Plasmid pBAD33‐*At*RbcLS for the expression of *A. thaliana* RbcL and RbcS; plasmid pET11a‐*At*C60αβ/C20 expressing the chloroplast chaperonin subunits Cpn60α, Cpn60β, and the chaperonin cofactor Cpn20; plasmid pDUET‐*At*R1/R2/RX/B2 expressing the Rubisco assembly chaperones Raf1.2, Raf2, RbcX and BSD2. Cam, chloramphenicol; Amp, ampicillin; Spec, spectinomycin; RBS, ribosome‐binding site. (B) Plasmids pET28‐*At*RbcLS and pET28‐*At*RbcLS^H^ ^is6^ for the simultaneous expression by IPTG induction of *A. thaliana* RbcL/RbcS (without or with a C‐terminal His6‐tag on RbcS, respectively) and plasmids pET11a‐*At*C60αβ/C20 and pDUET‐*At*R1/R2/RX/B2 (Fig. [2](#feb213352-fig-0002){ref-type="fig"}A). Kan, kanamycin.](FEB2-593-611-g002){#feb213352-fig-0002}

Bacterial cultures of each strain were prepared by picking colonies from agar plates and transferring them to 5 mL liquid LB media containing the required antibiotics. These starter cultures were incubated overnight at 37 °C and 220 r.p.m. shaking. The following day 500 μL of starter culture was used to inoculate 50 mL of the same media and incubated at 37 °C and 220 r.p.m. until the culture reached an OD~600~ of \~ 0.7. For simultaneous expression of chaperonin, auxiliary factors and Rubisco, cultures of *E. coli* harboring pET28b‐based Rubisco and chaperone expression plasmids were first equilibrated to 23 °C and then IPTG added to a final concentration of 0.5 m[m]{.smallcaps} and incubated at 23 °C at 150 r.p.m. for \~ 16 h. The following day, 40 mL of the culture was pelleted at 4000 ***g*** at 4 °C in 50 mL falcon tubes. The resulting pellet was processed immediately or flash‐frozen in liquid nitrogen and stored at −20 °C. To express the chaperone factors and Rubisco sequentially, *E. coli* cells harboring the plasmid pBAD33‐*At*RbcLS and the pET28b‐based chaperone expression plasmids were first induced with IPTG for 4 h, followed by centrifugation at 4000 ***g*** at 4 °C in 50 mL falcon tubes. The supernatant was discarded and the cell pellet resuspended in fresh 50 mL LB media containing antibiotics and 0.4% (w/v) [l]{.smallcaps}‐arabinose and incubated at 23 °C, 150 r.p.m., for \~ 16 h for expression of Rubisco [5](#feb213352-bib-0005){ref-type="ref"}. About 40 mL of the culture was pelleted as described above and either processed immediately or flash‐frozen in liquid nitrogen and stored at −20 °C.

The β isoform of Rubisco activase from *A. thaliana* (*At*Rcaβ) was expressed in *E. coli* BL21 cells transformed with pET28‐Ub‐*At*Rcaβ and plasmid p*Ec*EL/ES for overexpression of GroEL/ES chaperonin [5](#feb213352-bib-0005){ref-type="ref"} in presence of 0.3 m[m]{.smallcaps} IPTG for 10 h.

Protein purification {#feb213352-sec-0009}
--------------------

### Purification of Rubisco from *A. thaliana* leaves {#feb213352-sec-0010}

*Arabidopsis thaliana* leaves (60 g) were ground in the presence of liquid nitrogen. The resulting fine powder was suspended in extraction buffer (30 m[m]{.smallcaps} Tris pH 7.9, 4 m[m]{.smallcaps} EDTA, 5 m[m]{.smallcaps} DTT, 1 m[m]{.smallcaps} PMSF, 10% glycerol), filtered and centrifuged (57 000 ***g***, 30 min, 4 °C, TI45 rotor; Beckman Coulter, Brea, CA, USA). The clarified lysate was loaded on a self‐cast DEAE column equilibrated with buffer (30 m[m]{.smallcaps} Tris pH 7.9, 4 m[m]{.smallcaps} EDTA, 1 m[m]{.smallcaps} DTT), and the bound proteins were eluted by a salt gradient of NaCl (0--0.35 [m]{.smallcaps}). Fractions containing Rubisco were pooled and loaded on a HiPrep 26/60 Sephacryl S‐300 HR size‐exclusion chromatography (SEC) column (GE Healthcare, Chicago, IL, USA) equilibrated with SEC buffer (30 m[m]{.smallcaps} Tris pH 7.9, 1 m[m]{.smallcaps} EDTA, 1 m[m]{.smallcaps} DTT, 150 m[m]{.smallcaps} NaCl). Fractions containing Rubisco were pooled and concentrated; glycerol was added to a final concentration of 10% and aliquots stored at −80 °C.

### Purification of recombinant His‐tagged Rubisco {#feb213352-sec-0011}

Tagged Rubisco was purified from *E. coli* BL21 DE3(Star) cells transformed with plasmids pET11a‐*At*C60αβ/C20, pDUET‐*At*R1/R2/RX/B2, and pET28‐*At*RbcLS^His6^ and expressed in 6 L LB media, as described above, in the presence of 0.3 m[m]{.smallcaps} IPTG for 10 h at 23 °C. The cell pellet was resuspended in extraction buffer (30 m[m]{.smallcaps} Tris pH 7.9, 150 m[m]{.smallcaps} NaCl, 10 m[m]{.smallcaps} imidazole, 0.5 g·L^−1^ lysozyme, 5 U·mL^−1^ benzonase, 5% glycerol), disrupted by sonication and centrifuged (70 000 ***g***, 30 min, 4 °C, TI45 rotor; Beckman Coulter). The clarified lysate was then loaded on a nickel‐nitrilotriacetic acid (Ni‐NTA) column (HisTrap 5 mL; GE Healthcare) equilibrated with NTA buffer (30 m[m]{.smallcaps} Tris pH 7.9, 150 m[m]{.smallcaps} NaCl, 10 m[m]{.smallcaps} imidazole, 5% glycerol), and bound proteins were eluted using a gradient of imidazole (10--300 m[m]{.smallcaps}). Fractions containing Rubisco were pooled and loaded on a HiPrep 26/60 Sephacryl S‐300 HR column equilibrated with SEC buffer. Fractions containing Rubisco were then pooled, concentrated, and stored as above.

### Purification of recombinant Rubisco activase {#feb213352-sec-0012}

The β isoform of Rubisco activase from *A. thaliana* (*At*Rcaβ) was purified from *E. coli* BL21 DE3(Star) cells transformed with plasmid pET28‐Ub‐*At*Rcaβ and plasmid p*Ec*EL/ES and expressed in LB medium. *E. coli* cells were resuspended in extraction buffer (30 m[m]{.smallcaps} Tris pH 7.9, 150 m[m]{.smallcaps} NaCl, 10 m[m]{.smallcaps} imidazole, 0.5 g·L^−1^ lysozyme, 5 U·mL^−1^ Benzonase, 5% glycerol), disrupted by sonication and centrifuged (70 000 ***g***, 30 min, 4 °C, TI45 rotor; Beckman Coulter). The clarified lysate was then loaded on a Ni‐NTA column (HisTrap 5 mL; GE Healthcare) equilibrated with NTA buffer, and bound proteins were eluted using an imidazole gradient of 10--300 m[m]{.smallcaps}. Fractions containing Rubisco activase were pooled, treated by the deubiquitinase enzyme Usp2 (0.5 mg) [23](#feb213352-bib-0023){ref-type="ref"} in presence of 0.05% β‐mercaptoethanol for 3 h to remove the ubiquitin tag and loaded on a HiPrep 26/60 Sephacryl S‐300 HR column equilibrated with SEC buffer. Fractions containing AtRcaβ were pooled, concentrated, and stored as above.

All purified protein were quantified by absorbance at 280 nm using a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific) using extinction coefficients of 103 250 [m]{.smallcaps} ^−1^·cm^−1^ for *At*RbcLS (MW 73 153.2 Da) and *At*RbcLS^His6^ (MW 74 289.4 Da), and 36 270 [m]{.smallcaps} ^−1^·cm^−1^ for *At*Rcaβ (43 308 Da).

Cell fractionation and immunoblotting {#feb213352-sec-0013}
-------------------------------------

Bacterial pellets were resuspended in Rubisco extraction buffer consisting of 50 m[m]{.smallcaps} Tris‐HCl pH 8.0, 10 m[m]{.smallcaps} MgCl~2~, 1 m[m]{.smallcaps} EDTA, 30 m[m]{.smallcaps} NaHCO~3~, Complete™ protease inhibitor cocktail (Roche, Basel, Switzerland), 7.5 U·mL^−1^ *Serratia marcescens* nuclease (MPIB core facility), 1 mg·mL^−1^ lysozyme) and incubated on ice for 30 min. Cells were lysed by sonication using a Sonifier 250 (Branson Ultrasonics, Danbury, CT, USA) over a 5‐min duration with intensity setting 3 at 0.3 s sonic bursts. A sample of the resulting solution was taken as the 'total lysate' protein fraction and the soluble protein fraction was obtained by centrifugation at 16 000 ***g*** for 10 min at 4 °C. The protein amount in the soluble fraction was quantified by Bradford assay in UV flat bottom 96 well Microtitre^®^ plates (Thermo Fisher Scientific). Soluble protein fraction was diluted 100‐fold in deionized water and diluted in triplicate wells at a 10 : 140 μL ratio with deionized water. An equivalent volume of Coomassie plus™ protein assay reagent (Thermo Fisher Scientific) was added to each well and after 5 min absorption at 595 nm was measured using the Apollo 11 LB 913 microplate reader (Berthold Technologies, Bad Wildbad, Germany). Protein amount was determined relative to the BSA protein standardized curve in each plate, containing 0--2.25 μg gradient of high‐quality Pierce™ BSA (Thermo Fisher Scientific).

Soluble protein was diluted with 4× native‐PAGE loading buffer (200 m[m]{.smallcaps} Tris‐HCl, 0.4% bromophenol blue, 40% glycerol) and 20 μg of soluble protein lysate was loaded on Novex™ 4--12% Tris‐Glycine Native‐PAGE gradient mini gels (Thermo Fisher Scientific) followed by separation at 150 V for 90 min at 4 °C in 1× native‐PAGE running buffer (25 m[m]{.smallcaps} Tris‐HCl pH 8.3, 190 m[m]{.smallcaps} glycine). For SDS/PAGE analysis, soluble protein was diluted with 4× SDS/PAGE loading buffer \[200 m[m]{.smallcaps} Tris‐HCl pH 6.8, 0.4% bromophenol blue, 40% (v/v) glycerol, 8% (w/v) SDS\] and 12 μg of soluble or total protein lysate was loaded on Novex™ 4--12% Bis‐Tris NuPAGE gradient mini gels (Thermo Fisher scientific) followed by separation at 150 V for 90 min at 4 °C in 1× SDS/PAGE running buffer (50 m[m]{.smallcaps} MES pH 7.3, 50 m[m]{.smallcaps} Tris(hydroxymethyl)aminomethane, 0.1% (w/v) SDS, 1 m[m]{.smallcaps} EDTA).

Immunoblotting was performed using the semidry transfer method on in‐house constructed transfer modules. Protein was transferred to a 0.45 μm Amersham™ Protran™ nitrocellulose blotting membrane (GE Healthcare) at 275 mA for 50 min. Membranes were blocked in 5% (w/v) skim milk powder in TBS buffer (50 m[m]{.smallcaps} Tris‐HCl pH 7.5, 150 m[m]{.smallcaps} NaCl) for 1 h before probing with primary antibody for 45 min. Anti‐Rubisco antibody (raised against *Nicotiana tabacum* Rubisco) was a kind gift from S. Whitney (Australian National University). Membranes were then washed thoroughly in TBS buffer before probing with anti‐rabbit peroxidase conjugated IgG secondary antibody (Sigma‐Aldricht, St. Louis. MO, USA) for 45 min in TBS buffer. Immunoblots were visualized using an ImageQuant LAS4000 mini (GE Healthcare) imager immediately after exposure to Immobilon^®^ Classico western HRP substrate (Millipore, Burlington, MA, USA).

Rubisco carboxylation assay {#feb213352-sec-0014}
---------------------------

Carboxylation assays were performed using purified Rubisco protein or soluble bacterial protein extract in 1.5 mL Eppendorf tubes. Each tube contained 108 μL of assay buffer (50 m[m]{.smallcaps} Tris‐HCl pH 8.0, 10 m[m]{.smallcaps} MgCl, 1 m[m]{.smallcaps} EDTA, 30 m[m]{.smallcaps} NaHCO~3~), 2 μL of ^14^C labeled bicarbonate (\[^14^C\]‐NaHCO~3~) and 20 μL of 5 m[m d]{.smallcaps}‐ribulose‐1,5‐bisphosphate (RuBP; Sigma). The carboxylation assay at 25 °C was started by the addition of either 20 μL of soluble cell lysate or 20 μL of 62.5 nmol activated purified Rubisco, and stopped after 3 min by the addition of 50 μL of 50% (v/v) formic acid. Control reactions were in the absence of RuBP. Each assay set was accompanied by standard assays in quadruplicate. Standard assays were identical but contained 10‐fold less RuBP (20 μL of 0.5 m[m]{.smallcaps} RuBP), were started with the addition of 1 mg of purified Rubisco from *A. thaliana* leaves, and were reacted for at least 30 min to completely convert the RuBP to product. Stopped reactions were dried in heat blocks at 98 °C until all solvent was removed. Reaction residues were dissolved in 500 μL of Milli‐Q^®^ H~2~O and mixed with 750 μL of Rotiszint^®^ eco plus LCS‐Universalcocktail (Carl Roth, Karlsruhe, Germany) before measurement in an Aloka accuflex LSC‐8000 scintillation counter (Hitachi, Chiyoda, Tokyo, Japan). Total fixed CO~2~ can be determined per sample relative to the radioactivity of the standard assays which contained a known molar amount of RuBP. Rubisco in cell lysates was preactivated by the presence of NaHCO~3~ in the extraction buffer (50 m[m]{.smallcaps} Tris‐HCl pH 8.0, 10 m[m]{.smallcaps} MgCl~2~, 1 m[m]{.smallcaps} EDTA, 30 m[m]{.smallcaps} NaHCO~3~, Complete™ protease inhibitor cocktail (Roche), 7.5 U·mL^−1^ *S. marcescens* nuclease (MPIB core facility), 1 mg·mL^−1^ lysozyme).

Reactivation of Inhibited Rubisco {#feb213352-sec-0015}
---------------------------------

Inhibition of Rubisco was achieved by incubation of Rubisco in inactivation buffer (20 m[m]{.smallcaps} Tricine pH 7.9, 150 m[m]{.smallcaps} NaCl, 0.2 m[m]{.smallcaps} EDTA, N~2~ sparged) and subsequent incubation with 2 m[m]{.smallcaps} RuBP to generate the RuBP‐inhibited form (EI), or 20 m[m]{.smallcaps} NaHCO~3~ and 20 m[m]{.smallcaps} MgCl~2~ to generate the activated Rubisco (ECM).

Rubisco CO~2~ fixation was measured through the oxidation of NADH by a coupled enzymatic assay modified from Kubien *et al*. [25](#feb213352-bib-0025){ref-type="ref"} and Tsai *et al*. [26](#feb213352-bib-0026){ref-type="ref"}. Reactions were performed using Rubisco at a concentration of 0.375 μ[m]{.smallcaps} active sites, corresponding to 0.047 μ[m]{.smallcaps} Rubisco holoenzyme, and Rubisco activase (when indicated) at a concentration of 0.67 μ[m]{.smallcaps} hexamer. Reactions were initiated by the addition of Rubisco (and Rubisco activase) to the reaction buffer (100 m[m]{.smallcaps} Tricine pH 8.0, 10 m[m]{.smallcaps} MgCl~2~, 10 m[m]{.smallcaps} NaHCO~3~, 5 m[m]{.smallcaps} DTT, 2 m[m]{.smallcaps} RuBP, 0.5 m[m]{.smallcaps} NADH, 2 m[m]{.smallcaps} ATP, 5 U GAPDH, 5 U PGK, 5 U TIM, 5 U GPDH, 5 U creatine kinase).

Results {#feb213352-sec-0016}
=======

Improved Rubisco yields upon IPTG induction {#feb213352-sec-0017}
-------------------------------------------

The previous study achieving expression of functional *A. thaliana* Rubisco involved the generation of three plasmids for sequential expression of chaperones and Rubisco [5](#feb213352-bib-0005){ref-type="ref"} (Fig. [2](#feb213352-fig-0002){ref-type="fig"}A): The plasmid pBAD33‐*At*RbcLS for expression of RbcL and RbcS subunits of Rubisco under the control of the arabinose‐regulated pBAD promoter (*araC* regulated); the plasmid pET11a‐*At*C60αβ/C20 to express the chloroplast Cpn60 subunits α and β [2](#feb213352-bib-0002){ref-type="ref"}, and cofactor Cpn20 under the IPTG‐inducible T7 promoter; plasmid pDUET‐*At*R1/R2/RX/B2 for expression of Raf1, Raf2, RbcX, and BSD2, with each open reading frame (ORF) under control of the T7 promoter. Importantly, all ORFs are preceded by a ribosome‐binding site (RBS) (Fig. [2](#feb213352-fig-0002){ref-type="fig"}A). Plasmids pET11a‐*At*C60αβ/C20 and pDUET‐*At*R1/R2/RX/B2 were expressed for 3 h by induction with IPTG, followed by removal of IPTG and expression of Rubisco with arabinose for 18 h at 23 °C [5](#feb213352-bib-0005){ref-type="ref"}. While this strategy was successful, the discontinuous expression of the chaperones probably limited the yield of Rubisco. Indeed, transfer of the *AtrbcLS* operon to the pET28b vector (Fig. [2](#feb213352-fig-0002){ref-type="fig"}B) and simultaneous expression with the two chaperone plasmids (10 h at 23 °C) greatly improved the production of assembled Rubisco detectable by native‐PAGE, compared to sequential expression (Fig. [3](#feb213352-fig-0003){ref-type="fig"}A, lanes 1 and 3). Analysis of the carboxylation activity in equivalent amounts of *E. coli* lysate showed a \~ 6‐fold increase in Rubisco activity (Fig. [3](#feb213352-fig-0003){ref-type="fig"}B, lanes 1 and 3).

![Rubisco holoenzyme (*At*RbcL~8~S~8~) content in *Escherichia coli* cell extracts. (A) *Arabidopsis thaliana* chaperones and RbcL/RbcS were expressed either sequentially, as described previously [5](#feb213352-bib-0005){ref-type="ref"} (lane 1) or simultaneously (lanes 3 and 4) using the RbcL/RbcS plasmids indicated, with pET28b (lane 2) as empty vector control. RbcS was expressed either without (lane 3) or with C‐terminal His6‐tag (lane 4). Rubisco purified from *A. thaliana* leaves was used as standard (0.8 μg, lane 5). Soluble extracts of *E. coli* cells containing 20 μg of total protein were analyzed by native‐PAGE followed by Coomassie staining (left panel) or anti‐Rubisco immunoblotting (right panel). The position of *At*RbcL~8~S~8~ holoenzyme is indicated. (B) Rubisco carboxylation activity in the cell lysates analyzed in (A). Activity is expressed as nmol CO ~2~ fixed per minute in 1 mL of cell extract with a total protein concentration of 1 mg·mL^−1^. Error bars represent the SD of 8--18 measurements from *n* = 4 independent biological repeats.](FEB2-593-611-g003){#feb213352-fig-0003}

In order to facilitate purification of the holoenzyme, we attached a hexahistidine‐tag (His6‐tag) to the C terminus of RbcS to generate the plasmid pET28‐*At*RbcLS^His6^ (Fig. [2](#feb213352-fig-0002){ref-type="fig"}B). Interestingly, the expression of RbcS^His6^ doubled the yield of Rubisco holoenzyme and the carboxylation activity compared to the nontagged RbcS (Fig. [3](#feb213352-fig-0003){ref-type="fig"}A,B, lanes 3 and 4) resulting in a yield \~ 12‐fold higher than with arabinose induction of RbcL and RbcS (Fig. [3](#feb213352-fig-0003){ref-type="fig"}B, lanes 1 and 4).

Analysis of total *E. coli* lysate by SDS/PAGE showed that much higher levels of total and soluble RbcL and RbcS are produced under the T7 promoter, compared to arabinose induction (Fig. [4](#feb213352-fig-0004){ref-type="fig"}A,B, lanes 1 and 3). This is consistent with the 6‐fold higher yield of active Rubisco (Fig. [3](#feb213352-fig-0003){ref-type="fig"}B, lanes 1 and 3). Interestingly, the soluble RbcS was further increased when expressed with a His6‐tag (Fig. [4](#feb213352-fig-0004){ref-type="fig"}A,B, lanes 3 and 4). Thus, improved solubility of RbcS^His6^ compared to the nontagged RbcS is responsible for the further \~ 2‐fold increase in Rubisco production (Fig. [3](#feb213352-fig-0003){ref-type="fig"}B, lanes 3 and 4), resulting in a \~ 12‐fold yield increase compared to the previously published procedure [5](#feb213352-bib-0005){ref-type="ref"}.

![*At*RbcL and *At*RbcS content in total (A) and soluble (B) *Escherichia coli* lysate. Total and soluble lysate fractions (10 μg of protein) from cells expressing auxiliary factors and RbcL/RbcS either sequentially (lanes 1) or simultaneously (lanes 3 and 4) from the indicated plasmids as in Fig. [3](#feb213352-fig-0003){ref-type="fig"} were analyzed by SDS/PAGE and Coomassie staining. pET28b (lane 2) served as empty vector control and Rubisco purified from *Arabidopsis thaliana* leaves was used as standard (0.4 μg, lane 5). The positions of RbcL, RbcS and RbcS^6His^ are indicated. Note the increased amount of soluble RbcL and RbcS when RbcS is His6‐tagged.](FEB2-593-611-g004){#feb213352-fig-0004}

Purification and activity of His‐tagged Rubisco {#feb213352-sec-0018}
-----------------------------------------------

Using the improved expression system with pET28‐*At*RbcLS^His6^, we purified the recombinant *At*RbcL~8~S~8~ ^His6^ protein using a Ni‐NTA affinity column (see [Materials and methods](#feb213352-sec-0002){ref-type="sec"}) (Fig. [5](#feb213352-fig-0005){ref-type="fig"}A, lane 3 and Fig. [S1](#feb213352-sup-0001){ref-type="supplementary-material"}). Free RbcS^His6^ was removed by size‐exclusion chromatography (Fig. [5](#feb213352-fig-0005){ref-type="fig"}A, lane 4 and Fig. [S2](#feb213352-sup-0001){ref-type="supplementary-material"}). We obtained 75 mg of purified recombinant *At*RbcL~8~S~8~ ^His6^ from a 6 L culture of *E. coli*. The purity of the recombinant protein was comparable to that of Rubisco purified from leaves based on SDS/PAGE and analysis by native‐PAGE (Fig. [5](#feb213352-fig-0005){ref-type="fig"}B). The recombinant protein *At*RbcL~8~S~8~ ^His6^ showed a carboxylation activity similar to the enzyme purified from *A. thaliana* leaves (Fig. [5](#feb213352-fig-0005){ref-type="fig"}C), indicating that the tagged RbcS has no negative effect on Rubisco activity.

![Purification and characterization of recombinant *At*RbcL~8~S~8~ Rubisco. (A) Purification of *At*RbcL~8~S~8~ ^His6^. Total cell lysate, the pooled fractions upon elution from Ni‐NTA (Ni‐NTA pool) and the pooled fractions upon size‐exclusion chromatography (S300 pool) were analyzed by SDS/PAGE (2 μg protein for each sample) and Coomassie staining. The positions of RbcL and RbcS^H^ ^is6^ are indicated. (B) SDS/PAGE comparing purified *At*RbcL~8~S~8~ from *Arabidopsis thaliana* leaves (lane 1) and recombinant *At*RbcL~8~S~8~ ^His6^ (lane 2) by SDS/PAGE (left panel) and native‐PAGE (right panel). Two micrograms of protein was loaded. (C) Rubisco carboxylation activity of purified leaf *At*RbcL~8~S~8~ and recombinant *At*RbcL~8~S~8~ ^His6^. Activity is expressed as nmol CO ~2~ fixed per minute in 1 mL reactions containing 0.0625 μ[m]{.smallcaps} purified RbcL~8~S~8~. Error bars represent the SD of *n* = 6 independent measurements.](FEB2-593-611-g005){#feb213352-fig-0005}

Inhibited recombinant Rubisco can be reactivated by Rubisco activase {#feb213352-sec-0019}
--------------------------------------------------------------------

Catalytic activity of Rubisco requires activation of the newly assembled protein by carboxylation at the active‐site lysine by a nonsubstrate CO~2~ molecule followed by binding of Mg^2+^, a process called carbamylation [27](#feb213352-bib-0027){ref-type="ref"}. Premature binding of the substrate, RuBP, to uncarbamylated Rubisco results in an inactive enzyme [28](#feb213352-bib-0028){ref-type="ref"}. To activate the enzyme, the bound RuBP must be removed by Rubisco activase, an ATPase associated with various cellular activities (AAA+) protein, in an ATP‐dependent reaction [19](#feb213352-bib-0019){ref-type="ref"}, [29](#feb213352-bib-0029){ref-type="ref"}, [30](#feb213352-bib-0030){ref-type="ref"}, [31](#feb213352-bib-0031){ref-type="ref"}. Although the C‐terminal His6‐tag on RbcS did not impede the assembly and the carboxylation activity of the recombinant Rubisco, we next investigated whether the His6‐tag interferes with the recognition and subsequent reactivation of the inhibited enzyme by *A. thaliana* Rubisco activase β‐isoform (*At*Rcaβ) [32](#feb213352-bib-0032){ref-type="ref"}, [33](#feb213352-bib-0033){ref-type="ref"}, [34](#feb213352-bib-0034){ref-type="ref"}, [35](#feb213352-bib-0035){ref-type="ref"}. The uncarbamylated *At*RbcL~8~S~8~ ^His6^, like the leaf synthesized *At*RbcL~8~S~8~, could be inhibited by RuBP (EI), showing essentially no CO~2~ fixation as a function of time (Fig. [6](#feb213352-fig-0006){ref-type="fig"}A,B). Both RuBP‐inhibited Rubisco enzymes were efficiently reactivated by *At*Rcaβ in presence of ATP, reaching similar activities as the carbamylated enzymes (ECM) (Fig. [6](#feb213352-fig-0006){ref-type="fig"}A,B). These findings indicate that the C‐terminal His6‐tag on RbcS does not impede the recognition and remodeling of Rubisco by its cognate Rca.

![Reactivation of inhibited *At*RbcL~8~S~8~ (A) and *At*RbcL~8~S~8~ ^His6^ (B) by *Arabidopsis thaliana* Rubisco activase (*At*Rcaβ). RuBP‐inhibited Rubisco (EI) was incubated for reactivation with a 10‐fold molar excess of *A. thaliana* Rubisco activase (*At*Rcaβ) in the presence ATP (see [Materials and methods](#feb213352-sec-0002){ref-type="sec"}). Reactivation (red circles and red squares, respectively) was followed by measuring the amount of CO ~2~ in nmol fixed over time. Carbamylated Rubisco (Rubisco with CO ~2~ and Mg^2+^‐bound; ECM) (black circles and black squares, respectively) and inhibited Rubisco (EI) (empty circles and empty squares, respectively) were analyzed as controls. The maximum rates of CO ~2~ fixation for ECM and EI in the presence of *At*Rcaβ and ATP are indicated in CO ~2~·s^−1^ per Rubisco active site. The error bars represent SD of *n* = 3 independent experiments.](FEB2-593-611-g006){#feb213352-fig-0006}

Discussion {#feb213352-sec-0020}
==========

We have shown here that production of plant Rubisco in *E. coli* is best achieved using high induction and/or high copy number vectors for RbcL and RbcS expression. Simultaneous rather than sequential expression of chaperones and Rubisco allows for efficient folding and assembly of the plant Rubisco. An important additional improvement in Rubisco yield was achieved by attaching a C‐terminal hexahistidine‐tag to RbcS. This resulted in stabilization of RbcS in a soluble state competent for assembly. In the previously published expression scheme, expression of RbcS was apparently limiting for Rubisco holoenzyme formation, which resulted in the accumulation of the penultimate assembly intermediate of RbcL with bound chaperone BSD2 (RbcL~8~BSD2~8~) [5](#feb213352-bib-0005){ref-type="ref"}. Displacement of BSD2 by RbcS completes holoenzyme formation [5](#feb213352-bib-0005){ref-type="ref"}, [36](#feb213352-bib-0036){ref-type="ref"}. Apparently, the higher levels of RbcS achieved with the tagged protein increased the efficiency of this process, and avoided the accumulation of the BSD2 assembly intermediate observed with the sequential expression scheme [5](#feb213352-bib-0005){ref-type="ref"}. The limited stability and hence solubility of unassembled RbcS above a concentration of \~ 2 mg·mL^−1^ [13](#feb213352-bib-0013){ref-type="ref"} may suggest a specific chaperone requirement. Indeed, RbcS folds following import into chloroplasts in a reaction involving the organellar Hsp70 chaperone system [37](#feb213352-bib-0037){ref-type="ref"}, [38](#feb213352-bib-0038){ref-type="ref"}. Thus, additional overexpression of Hsp70 system in *E. coli* may further improve solubility. The C‐terminal His6‐tag on RbcS also facilitated the purification of recombinant Rubisco holoenzyme. Importantly, the tagged Rubisco was fully functional and the RuBP‐inhibited enzyme was efficiently recognized by the AAA+ protein Rubisco activase.

The improved expression method as well as the facile and efficient purification protocol described here provides a versatile platform for studies involving functional and structural characterization of mutations of higher plant Rubisco. As the pET28 and pET11a plasmids (for expression of Rubisco and chaperonins, respectively) share the pBR322 origin of replication, the long‐term coexistence of these plasmids may result in variation of copy number and thus fluctuations in expression levels [39](#feb213352-bib-0039){ref-type="ref"}. Thus, applications sensitive to fluctuations of Rubisco expression, such as directed evolution screening [40](#feb213352-bib-0040){ref-type="ref"}, [41](#feb213352-bib-0041){ref-type="ref"} or metabolic engineering [42](#feb213352-bib-0042){ref-type="ref"}, [43](#feb213352-bib-0043){ref-type="ref"}, [44](#feb213352-bib-0044){ref-type="ref"}, may require the use of compatible plasmids.
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**Fig. S1.** Purification of *At*RbcL~8~S~8~ ^His6^ by Ni‐NTA affinity chromatography.

**Fig. S2.** Size‐exclusion chromatography of pooled fractions of *At*RbcL~8~S~8~ ^His6^ obtained by Ni‐NTA affinity chromatography.
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